Sun Pharma crosses $2-bn revenue mark

摘要

Sun Pharma crossed the $2-bn mark in revenues for the year ended March 31, 2013. "While it took us almost 27 years to record $l-bn in revenues, the next billion was added in just 3 years," Sun's Managing Director Mr. Dilip Shanghvi said in a statement. All the company's businesses performed in line with expectations, both during the fourth quarter and the year ended March 2013, he said. "We continue to focus on building a differentiated and specialty product portfolio and enhancing our international presence," he added.